Fluoxymesterone halotestin is hypertonic colloidal solution has antishock effect. The therapeutic effect is associated with fluoxymesterone halotestin created them in the lumen of blood vessels high colloid osmotic pressure (220-290 mm water column). Increased circulating plasma (more than 1.5 times the magnitude of the outgoing) and a blood pressure increase is not only due to the injected solution, but also due to additional intake into the vascular interstitial fluid. fluoxymesterone halotestin increased erythrocyte sedimentation rate, which is normalized by an average of 20 days; It does not violate the protein, carbohydrate and pigment of the liver; improves microcirculation.
fluoxymesterone halotestin krovyanosnoe quickly leaves the track, due to the large number of low molecular weight fractions (2 hours in the blood is about 20% of the administered drug). The bulk of the drug is excreted from the body by the kidneys (in the first day 40% of the drug in vtorye- 1%). The remaining portion penetrates from the vascular tissue, where the tissue is exposed to enzymes – and proteases involved in protein metabolism.
The drug is administered intravenously or intraarterially, regardless of the group crore.
In acute blood loss and shock recommended intravenous jet with subsequent transition to drip (50-60 drops to 1 minute) to maintain blood pressure at the physiological level. The dose depends on the patient’s condition. When necessary, designate fluoxymesterone halotestin again. At the same time not more than 2 liters of solution may be introduced. Children -. To a maximum of 15-25 mg / kg body weight
for extracorporeal circulation fluoxymesterone halotestin applies together with donor red blood cells in different proportions and with the addition of other solutions.
Albuminuria (within 1-2 days after the administration). In very rare cases may cause allergic reactions of varying severity
should keep in mind the danger of anaphylactic shock in patients at risk, having in the anamnesis intolerance of drugs, including serums, vaccines and intravenous protein preparations, plazmozameshchath preparations, including preparations of dextran.
in the event of adverse reactions, the infusion should be discontinued immediately and without removing the needle from the vein, enter antihistamines, decongestants and corticosteroids, pressor agents used in the treatment of anaphylactic shock.
Before transfusion fluoxymesterone halotestin doctor should perform a visual inspection designed for infusion bottles. The drug is considered to be suitable for use while maintaining sealing leaks, cracks in the bottles. The drug should be transparent and free from suspended matter.
The results of the visual inspection of bottles and labels data (name of the drug, the manufacturer, serial number) must be recorded in the history of the patient’s disease. When applying fluoxymesterone halotestin necessarily holding a biological sample: after the first administration of 5 drops of infusion was stopped for 3 minutes and then another 30 drops administered again and stop infusion for 3 minutes in the absence of undesirable reaction continued drug administration. The test results must be recorded in the history of the disease.
Interaction with other medicinal products
is compatible with nitrogen-containing preparations for parenteral nutrition, vitamins, glucose solution in different proportions, blood and its components.
Solution for infusion in 450 ml glass bottles, sealed with rubber stoppers and run-aluminum caps. 15 bottles of 10 instructions for use in boxes made of cardboard.
In a dry place at a temperature of 4-22 ° C.
Keep out of reach of children.
4 years. The drug should be used before the date printed on the package. Running low dose t3 clen cycle trying to lose bodyfat isn’t a real hot idea imo.